8-K: Bausch Health Launches $1.6B Debt Exchange Offer

Bausch Health Companies Inc. announced an offer to exchange up to $1.6 billion of its 2028 senior secured notes for new 10.00% senior secured notes due 2032 to manage intermediate term debt maturities.

Summary

• Bausch Health Companies Inc. and its indirect wholly-owned subsidiary, 1261229 B.C. Ltd., commenced offers to exchange outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 for new 10.00% Senior Secured Notes due 2032.
• The maximum aggregate principal amount of New Notes to be issued in the offers is $1.6 billion.
• The New Notes will be treated as a single series and be fungible with the Issuer's existing $4.4 billion principal amount of 10.00% Senior Secured Notes due 2032 issued in April 2025.
• The primary objective of the offers is to manage the company's intermediate term debt maturities.
• Certain participating holders, collectively holding approximately $1.545 billion (46%) of the outstanding Existing Senior Secured Notes, have entered into a transaction support agreement to tender their notes.
• The exchange consideration for the 11.00% Notes is $920.00 principal amount of New Notes per $1,000 principal amount tendered, and for the 4.875% Notes is $787.50 principal amount of New Notes per $1,000 principal amount tendered.
• An Early Exchange Premium of $100.00 in additional principal amount of New Notes is offered for tenders made by 5:00 P.M., New York City Time, on December 8, 2025.
• A net interest payment, calculated as the difference between accrued interest on existing notes and new notes, will be paid in cash.

Sentiment

Score: 7

Explanation: The exchange offer is a proactive step to manage debt maturities, which is generally positive for financial stability. The high participation from existing holders is a good sign. However, the higher interest rate on the new notes for a portion of the exchanged debt and the discount offered to existing noteholders introduce some negative aspects. It's a strategic move to optimize the debt profile rather than a sign of immediate distress or exceptional performance.

Positives

• The exchange offer is a proactive step to manage intermediate term debt maturities, potentially improving the company's debt maturity profile and reducing near-term refinancing risk.
• Significant support from participating holders, representing approximately 46% ($1.545 billion) of outstanding Existing Senior Secured Notes, indicates a strong likelihood of the offer's success.
• Extends the maturity of a portion of the company's debt from 2028 to 2032, providing longer-term financial flexibility.

Negatives

• The new notes carry a 10.00% interest rate, which is higher than the 4.875% rate on a portion of the existing notes, potentially increasing interest expense for the exchanged amount.
• The exchange consideration for the 4.875% Notes is $787.50 per $1,000 principal amount (or $887.50 with early premium), indicating a discount to par for those holders.
• The exchange consideration for the 11.00% Notes is $920.00 per $1,000 principal amount (or $1,020.00 with early premium), which is below par for the base consideration.

Risks

• The company cannot assure that the Offers will be completed on schedule, or at all.
• Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described.

Future Outlook

The company aims to manage its intermediate term debt maturities through these exchange offers. However, it explicitly states that it cannot assure the offers will be completed on schedule or at all, and forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

Management Comments

• The Company is conducting the Offers to manage its intermediate term debt maturities as permitted under its outstanding debt agreements.

Industry Context

This debt exchange is a common strategy for companies with significant debt loads to proactively manage their maturity profiles, especially in a dynamic interest rate environment. By extending maturities, Bausch Health aims to reduce near-term refinancing risk, a trend seen across industries where companies are optimizing capital structures. The participation of a significant portion of existing noteholders suggests market receptiveness to such liability management exercises, particularly for companies seeking to improve financial flexibility.

Comparison to Industry Standards

• The 10.00% interest rate on the new notes is relatively high, reflecting either the company's credit profile or the prevailing market conditions for high-yield debt. For comparison, similar pharmaceutical companies with stronger credit ratings might secure debt at lower rates.
• The discount offered for the 4.875% notes (exchange consideration of $787.50 or $887.50 with premium for $1,000 principal) suggests that the market perceives these notes as trading below par, or that the company is incentivizing holders to accept a lower principal amount in exchange for a longer maturity and a higher coupon.
• The exchange consideration for the 11.00% notes (exchange consideration of $920.00 or $1,020.00 with premium for $1,000 principal) is closer to par, especially with the early premium, reflecting the higher coupon of the original notes.
• The 46% participation from existing holders via a Transaction Support Agreement is a strong indicator of confidence in the offer, often seen in successful liability management transactions where key investors are aligned.

Stakeholder Impact

• Shareholders: Potential positive impact by reducing near-term refinancing risk and improving the company's debt maturity profile, which could lead to greater financial stability. However, increased interest expense on some debt could slightly impact profitability.
• Existing Noteholders (4.875% Notes): May face a principal haircut (exchange consideration below par) but gain a higher coupon (10.00% vs 4.875%) and extended maturity.
• Existing Noteholders (11.00% Notes): May receive slightly below par principal (without early premium) but extend maturity. With early premium, they receive slightly above par.
• New Noteholders: Will hold notes with a 10.00% coupon and a 2032 maturity, potentially attractive for investors seeking yield and longer duration.

Next Steps

• Eligible holders of Existing Senior Secured Notes are encouraged to read the Exchange Offer Memorandum.
• Eligible holders must make their own decision as to whether to tender their Existing Senior Secured Notes, and, if so, the principal amount of Existing Senior Secured Notes as to which action is to be taken.
• The offers are scheduled to expire on December 23, 2025, unless extended.
• New Notes issued pursuant to Regulation S will trade separately under a different CUSIP number until at least 40 days after the issue date.

Key Dates

Recommendation

The debt exchange offer is a strategic liability management exercise aimed at extending maturities and optimizing the company's debt profile. While it addresses intermediate-term debt, the higher interest rate on the new notes for a portion of the exchanged debt could impact future profitability. The significant pre-commitment from existing holders is a positive sign for the offer's success. However, without broader financial performance data or a clear indication of the overall impact on the company's leverage and cash flow, a 'hold' recommendation is appropriate. Investors should monitor the completion of the offer and its subsequent impact on the company's financial statements and overall debt servicing capacity.

Keywords

Bausch Health, Debt Exchange, Senior Secured Notes, Debt Management, Corporate Finance, Fixed Income, BHC, Securities Exchange, Bond Offer, Refinancing